It seems like Orioles’ starter Jeremy Guthrie has been a named candidate for a midseason trade since sometime during the Nixon administration. And he fits the bill: a good starter but no ace, playing for a team that isn’t going anywhere and not yet expensive. Heck, a lot of teams would like to have someone like that.
Jeff Zrebiec of the Baltimore Sun does not think Guthrie will be traded, however. It’s just a little tidbit buried in his notes column this morning, but it’s Zrebiec’s view that the O’s will keep him, either until this winter or maybe even until next season’s trading deadline.
Zrebiec’s take on the state of the O’s is almost always a good one and a smart one. I wish he’d explain this a bit more here, however, because I don’t quite get why Baltimore wouldn’t shop him (of if he has explained so in the past and I have just missed it, I’d ask that someone point me to his reasoning). Because Guthrie is the archetypal midseason trade bait, no?
Rangers reliever Jake Diekman will have surgery on January 25 to help alleviate ulcerative colitis, an inflammatory bowel disease. As a result, the lefty will miss at least half of the 2017 regular season, Jeff Wilson of the Fort Worth Star-Telegram reports. Diekman was diagnosed with the illness when he was 11 years old. He has brought awareness to the Crohn’s and Colitis Foundation of America with a “Gut It Out” campaign.
Diekman, who turns 30 years old on Saturday, finished the 2016 campaign with a 3.40 ERA and a 59/26 K/BB ratio in 53 innings. He came to the Rangers from the Phillies in the Cole Hamels trade on July 31, 2015.
The Rangers and Diekman avoided arbitration last Friday, agreeing to a $2.55 million salary for the 2017 season.
It’s been on the verge of happening for a few days now, but now it’s official: the Toronto Blue Jays and Jose Bautista have reached a one-year deal with a mutual option. The deal is pending physical. An announcement making the deal official is expected later in week.
The exact financial figures have not been disclosed, but Jon Heyman reports that it will be in excess of the $17.2 million Bautista turned down when he turned down the Jays’ qualifying offer.
Bautista had a tough 2016, hitting .234/.366/.452 with 22 home runs and 69 RBI, and some clubs likely considered a long-term deal for the 36-year-old too risky, this leading to the relative lack of reported interest in Bautista by other clubs. But back-to-back ALCS appearances by the Jays and the success and popularity Bautista has experienced in Toronto make his re-signing there a pretty sensible move for all involved.